{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:40:42Z","timestamp":1760298042168},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2403,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1111\/j.1872-034x.2008.00414.x","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T06:47:43Z","timestamp":1232520463000},"page":"117-125","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon \u03b1-2b for advanced hepatocellular carcinoma with portal venous invasion: preliminary results"],"prefix":"10.1111","volume":"39","author":[{"given":"Kazuhiro","family":"Kasai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekatsu","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Sawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB1","first-page":"S21","article-title":"Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography: a study in 51 patients","volume":"2","author":"Shinagawa","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2214\/ajr.147.3.525","article-title":"Angiography of small hepatocellular carcinomas: analysis of 105 resected tumors","volume":"147","author":"Takayasu","year":"1986","journal-title":"Am J Roentgenol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004728-198501000-00004","article-title":"Dynamic computed tomography during arterial portography; the most sensitive examination for hepatocellular carcinomas","volume":"9","author":"Matsui","year":"1985","journal-title":"J Comput Assist Tomogr"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB4","first-page":"176","article-title":"Transcatheter arterial embolization (TAE) in treatment for hepatoma-analysis of three-year survivors","volume":"3","author":"Ohtomo","year":"1985","journal-title":"Radiat Med"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2214\/ajr.154.5.2157329","article-title":"Percutaneous ethanol injection therapy for treatment of hepatocellular carcinoma","volume":"154","author":"Shiina","year":"1990","journal-title":"Am J Roentgenol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB6","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1053\/gast.1996.v110.pm8613057","article-title":"Microwave coagulation therapy for hepatocellular carcinoma","volume":"110","author":"Sato","year":"1996","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1111\/j.1872-034X.2008.00414.x-BIB7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000048278","article-title":"Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation","volume":"62","author":"Shiina","year":"2002","journal-title":"Oncology"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00000658-198807000-00004","article-title":"Treatment of cancer of the liver: twenty years\u2019 experience with infusion and resection in 414 patients","volume":"208","author":"Stehlin","year":"1998","journal-title":"Ann Surg"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB9","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/1097-0142(19880515)61:10<1983::AID-CNCR2820611009>3.0.CO;2-V","article-title":"Intrahepatic chemotherapy for unresectable hepatocellular carcinoma","volume":"61","author":"Doci","year":"1988","journal-title":"Cancer"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB10","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/1097-0142(197510)36:4<1250::AID-CNCR2820360410>3.0.CO;2-X","article-title":"Treatment of hepatocellular carcinoma with adriamycin","volume":"36","author":"Olweny","year":"1975","journal-title":"Cancer"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cncr.10246","article-title":"Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches","volume":"94","author":"Sakon","year":"2002","journal-title":"Cancer"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB12","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/cncr.21832","article-title":"Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion","volume":"106","author":"Obi","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1067\/mcp.2000.110973","article-title":"Pegylated interferon-a2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data","volume":"68","author":"Paul","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB15","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S1051-0443(07)61682-0","article-title":"Intraarterial chemotherapy of liver metastasis: implantation of microcatheter-port system with use of modified fixed catheter tip technique","volume":"12","author":"Irie","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB18","unstructured":"18\u2002NCI Common Toxicity Criteria. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). [Cited 9 August 2006.] Available from URL: http:\/\/ctep.cancer.gov\/reporting\/ctc.html"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB19","first-page":"105","article-title":"Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis","volume":"23","author":"Fujii","year":"1993","journal-title":"Jpn J Clin Oncol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1746.1994.tb01207.x","article-title":"Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by transcatheter arterial chemo-embolization","volume":"9","author":"Chen","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB21","first-page":"637","article-title":"Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein","volume":"43","author":"Tanaka","year":"1996","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB22","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<1890::AID-CNCR8>3.0.CO;2-K","article-title":"A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein","volume":"79","author":"Ando","year":"1997","journal-title":"Cancer"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients","volume":"28","author":"The Cancer of the Liver Italian Program (CLIP) Investigators","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB24","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0006-291X(92)91863-L","article-title":"Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells","volume":"182","author":"Schwartz","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB25","first-page":"3473","article-title":"Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review","volume":"50","author":"Wadler","year":"1990","journal-title":"Cancer Res"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-291X(89)92302-4","article-title":"Interferon effects upon fluorouracil metabolism by HL-60 cells","volume":"163","author":"Elias","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB27","first-page":"1277","article-title":"Combination of IFN-a and 5-fluorouracil induces apoptosis through IFN-a\/\u00df receptor in human hepatocellular carcinoma cells","volume":"11","author":"Kondo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000040929","article-title":"Synergistic effects of retrovirus IFN-alpha gene transfer and 5-FU on apoptosis of colon cancer cells","volume":"101","author":"Sabaawy","year":"1999","journal-title":"Acta Haematol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB29","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.510290624","article-title":"Interferon alpha receptor expression and growth inhibition by interferon alpha in human liver cell lines","volume":"29","author":"Yano","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB30","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1038\/sj.onc.1202609","article-title":"Molecular mechanisms underlying interferon alpha-induced G0\/G1 arrest: CKI-mediated regulation of G1 CDK-complexes and activation of pocket proteins","volume":"18","author":"Sangfelt","year":"1999","journal-title":"Oncogene"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.240500102","article-title":"Cytokine triggered molecular pathways that control cell cycle arrest","volume":"50","author":"Kimchi","year":"1992","journal-title":"J Cell Biochem"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jnci\/81.7.502","article-title":"Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells","volume":"81","author":"Guadagni","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.2910310306","article-title":"Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes","volume":"31","author":"Ortaldo","year":"1983","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1073\/pnas.69.3.721","article-title":"Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes","volume":"69","author":"Lindahl","year":"1972","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB35","first-page":"1320","article-title":"Direct and indirect effects of interferon on in vivo murine tumor cell growth","volume":"45","author":"Uno","year":"1985","journal-title":"Cancer Res"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1478-3231.2006.01321.x","article-title":"Growth inhibitory effects of pegylated IFNa-2b on human liver cancer cells in vitro and in vivo","volume":"26","author":"Yano","year":"2006","journal-title":"Liver Int"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB37","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.3748\/wjg.v11.i34.5401","article-title":"Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon","volume":"11","author":"Kurokohchi","year":"2005","journal-title":"World J Gastrol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhep.2006.03.008","article-title":"A randomized trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE)","volume":"45","author":"Silva","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB39","first-page":"260","article-title":"Combination therapy of intra arterial 5FU and systemic interferon-a for advanced hepatocellular carcinoma with portal venous invasion","volume":"43","author":"Obi","year":"2006","journal-title":"Gastroenterology (Tokyo)"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB40","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2036.2004.02170.x","article-title":"Review article: pegylated interferons: chemical and clinical differences","volume":"20","author":"Foster","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB41","first-page":"1391","article-title":"Cellular basis for the inefficacy of 5-FU in human colon carcinoma","volume":"69","author":"Drewinko","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002800050788","article-title":"Apoptosis-and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model","volume":"42","author":"Guchelaar","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB43","first-page":"253","article-title":"Breakthrough of the hepatic arterial infusion chemotherapy of hepatocellular carcinoma","volume":"43","author":"Ueshima","year":"2006","journal-title":"Gastroenterology (Tokyo)"},{"key":"10.1111\/j.1872-034X.2008.00414.x-BIB44","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/AAC.47.6.1912-1921.2003","article-title":"Ribavirin and alpha interferon enhance death receptor-mediated apoptosis and caspase activation in human hepatoma cells","volume":"47","author":"Stephan","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Hepatology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1872-034X.2008.00414.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1872-034X.2008.00414.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T02:26:25Z","timestamp":1625624785000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1872-034X.2008.00414.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1872-034x.2008.00414.x","relation":{},"ISSN":["1386-6346","1872-034X"],"issn-type":[{"value":"1386-6346","type":"print"},{"value":"1872-034X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}